Premium
Therapy of Hyperlipidemia in ESRD
Author(s) -
Perez Guido O.
Publication year - 1989
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/j.1525-139x.1989.tb00552.x
Subject(s) - medicine , hyperlipidemia , dialysis , drug , population , intensive care medicine , pharmacology , endocrinology , diabetes mellitus , environmental health
Elevated serum levels of triglycerides and cholesterol are common in dialysis patients. It seems a p parent that a population with a shorter llf'e expectancy and a higher risk of drug toxicity should have a diferent threshold for drug intervention than the general population. When should lipid abnormalities in dialysis patients be treated with medication?